… approach could be appropriate to better target the use of corticosteroids in patients to prevent
and treat COPD exacerbations. The presence of an elevated sputum eosinophil count in …

… Despite the lack of high-quality evidence, there is a consensus that short-acting inhaled β 2
-agonists and short-acting anticholinergics are the initial treatment of COPD exacerbations [3…

… the 2 weeks prior to an exacerbation and returning to baseline values ∼… medication used
to treat the exacerbation, with a similar absolute change in symptom score for episodes treated …

… risk of frequent exacerbations. Exacerbations become more frequent and severe as COPD
… respiratory virus infection and acute exacerbations of COPD. In that study, 13 subjects with …

… The first step in treating a COPD exacerbation is increasing the dosage of albuterol delivered
via metered dose inhaler or nebulizer. Levalbuterol is more expensive than albuterol but …

… on patients’ health status, their frequency is now recognized as a key component of the
characterization of patients with COPD, and the prevention and treatment of exacerbations has …

… First, the screening process from the pharmacy records used for this study only allowed
inclusion of patients who were treated with antibiotics for an acute exacerbation of COPD. It is …

… pharmacological treatment of acute exacerbations of COPD has changed relatively little over
the last two decades. Oral corticosteroids are used to shorten the length of the exacerbation…

… Short-acting inhaled β2-agonists are the preferred initial bronchodilator for the treatment
of acute exacerbations of COPD [17–20]. Although usually given in nebulised form there is …

… Many novel treatments have failed to prevent exacerbations. … single medicine treating a
heterogeneous disease such as COPD … medicine may have a role in preventing exacerbations in …